Prostate-Cancer Test Not Worth Risk, Advisory Panel Says
By Alex Nussbaum - May 21, 2012 4:00 PM CT
"The PSA prostate-cancer test used by half of U.S. men older than 40 carries more risks than benefits and shouldn’t be used to diagnose the disease, a U.S. panel said, reaffirming its earlier advice.
Scientific studies suggest the number of deaths avoided by screening are “very small” compared with risks from testing or treatment that can include infections, incontinence, erectile dysfunction and death, the U.S. Preventive Services Task Force said in a medical journal today. The 16-doctor panel kept its recommendation from last October after some doctors and patient groups said discouraging the tests would cost lives."
No comments:
Post a Comment